Interleukin-7 receptor expression in cutaneous T-cell lymphomas

British Journal of Dermatology

Volumn 135, Issue 4, 1996, Pages 572-575

  Bagot, M ^a   Charue, D ^a   Boulland, M L ^a   Gaulard, P ^a   Revuz, J ^a   Schmitt, C ^a,b   Wechslker, J ^a  

^a HENRI MONDOR HOSPITAL   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD30 ANTIGEN; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 7 RECEPTOR;

ARTICLE; B CELL LYMPHOMA; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; PRIORITY JOURNAL; T CELL LYMPHOMA;

EID: 0029826860     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.1996.tb03833.x     Document Type: Article

References (23)

1. Edelson R. Cutaneous T-cell lymphoma: mycosis fungoides, Sézary syndrome and other variants. J Am Acad Dermatol 1980: 2: 89-106.
2. Bagot M, Wechsler J. Lescs MC et al. Intraepidermal localization of the clone in cutaneous T-cell lymphomas. J Am Acad Dermatol 1992; 27: 589-93.
3. Stansfeld AG, Diebold J, Kapanci Y et al. Updated Kiel classification for lymphomas. Lancet 1988; i: 292-3.
4. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms. A proposal from the international lymphoma study group. Blood 1994; 84: 1361-92.
5. Beljaards RC, Meijer CJLM. Scheffer E et al. Prognostic significance of CD30 (Ki-1/Ber-H2) expression in primary cutaneous large cell lymphomas of T-cell origin. Am J Pathol 1989; 135: 1169-78.
6. Beljaards RC, Meijer CJLM, van der Putte SCJ et al. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma. J Pathol 1994; 172: 53-60.
7. Friedmann D, Wechsler J, Delfau MH et al. Primary cutaneous pleomorphic small T-cell lymphoma. Arch Dermatol 1995; 131: 1009-15.
8. Watson JD, Morrisey PJ, Namen AE et al. Effect of IL-7 on the growth of fetal thymocytes in culture. J Immunol 1989; 143: 1215-22.
9. Chazen GD, Pereira GM, LeGros G et al. Interleukin-7 is a T-cell growth factor. Proc Natl Acad Sci USA 1989; 86: 5923-7.
10. Dalloul A, Laroche L, Bagot M et al. Interleukin-7 is a growth factor for Sézary lymphoma cells. J Clin Invest 1992; 90: 1054-60.
11. Foss FM, Koc Y, Stetler-Stevenson MA et al. Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2. Potential autocrine or paracrine effectors in the Sézary syndrome. J Clin Oncol 1994; 12: 326-35.
12. Heufler C, Topar G, Grasseger A et al. Interleukin 7 is produced by murine and human keratinocytes. J Exp Med 1993; 178: 1109-14.
13. Rich BE, Campos-Torres J, Tepper RI et al. Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice. J Exp Med 1993; 177: 305-16.
14. Cordell JL, Falini B, Erber W et al. Immunoenzymatic labeling of antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219-29.
15. Luger TA, Schwarz T, Evidence for an epidermal cytokine network. J Invest Dermatol 1990; 95: S100-4.
16. Overall RW, Clark L, Lynch D et al Interleukin-7 retroviruses transform pre-B cells by an autocrine mechanism not evident in Abelson murine leukemia virus transformants. Mol Cell Biol 1991; 11: 1590-7.
17. Ralfkiaer E, Wantzin GL, Mason DY et al. Phenotypic characterization of lymphocyte subsets in mycosis fungoides. Comparison with large plaque parapsoriasis and benign chronic dermatoses. Am J Clin Pathol 1985; 84: 610-19.
18. Abrams JT, Lessin S, Ghosh S et al. Malignant and nonmalignant T cell lines from human lymphotropic virus type I-negative patients with Sézary syndrome. J Immunol 1991; 146: 1455-62.
19. Ho VC, Baadsgaard O, Elder JT et al. Genotypic analysis of T-cell clones derived from cutaneous T-cell lymphoma lesions demonstrates selective growth of tumor-infiltrating lymphocytes. J Invest Dermatol 1990; 95: 4-8.
20. Noguchi M, Nakamura Y, Russel SM et al. Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor. Science 1993; 262: 1877-80.
21. Smith CA, Gruss HJ, Davis T et al. CD30 antigen, a marker for Hodgkin's lymphoma. is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell 1993; 73: 1349-60.
22. Beljaards RC, Kaudewitz P, Berti E et al. Primary cutaneous CD-30 positive large cell lymphoma. Definition of a new type of cutaneous lymphoma with a favourable prognosis. Cancer 1993; 71: 2097-104.
23. Kawano M, Hirano T, Matsuda T et al. Autocrine generation and requirement of BSF-2/IL6 for human multiple myelomas. Nature 1988; 332: 83-5.